Splenic rupture in a patient with advanced gastric cancer receiving ramucirumab

Splenic rupture in a patient with advanced gastric cancer receiving ramucirumab

Bibliographic Details
Main Authors:	Esther Legaria Gaztambide, Amparo Lucena Campillo, Francisco José Hidalgo Correas, Benito García Díaz
Format:	Article
Language:	English
Published:	Grupo Aula Médica 2016-07-01
Series:	Farmacia Hospitalaria
Online Access:	http://www.aulamedica.es/fh/pdf/10518.pdf

Similar Items

Clinical utility of ramucirumab in advanced gastric cancer
by: Chan MMK, et al.
Published: (2015-09-01)

Ramucirumab for advanced gastric cancer or gastro-oesophageal junction adenocarcinoma
by: Kate Young, et al.
Published: (2015-11-01)

Critical evaluation of ramucirumab in the treatment of advanced gastric and gastroesophageal cancers
by: ElHalawani H, et al.
Published: (2015-07-01)

Endoscopic Ultrasound-Guided Drainage of Intra-Abdominal Abscess after Gastric Perforation in a Patient Receiving Ramucirumab and Paclitaxel for Advanced Gastric Cancer
by: Koichiro Mandai, et al.
Published: (2017-01-01)

Ramucirumab therapy in patients with advanced gastric cancer: discussion of a case series
by: R V Orlova, et al.
Published: (2018-03-01)

Retrospective observational study of salvage line ramucirumab monotherapy for patients with advanced gastric cancer
by: Sadayuki Kawai, et al.
Published: (2020-04-01)

Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer
by: Mashiro Okunaka, et al.
Published: (2020-11-01)

Ramucirumab in patients with advanced gastric and gastroesophageal junction cancer: Learnings from East Asian data
by: Chia-Jui Yen, et al.
Published: (2018-06-01)

Splenic abscess leading to spontaneous splenic rupture
by: Annum A. Bhullar, et al.
Published: (2021-03-01)

The Impact of Ramucirumab Treatment on Survival and Quality of Life in Patients with Gastric Cancer
by: Mehta R, et al.
Published: (2020-01-01)

A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites
by: Hiroshi Matsumoto, et al.
Published: (2018-01-01)

Ramucirumab: Boon or bane
by: Priya Tiwari
Published: (2016-09-01)

Atraumatic splenic rupture precipitated by splenic vein thrombosis
by: Qiao Zhou, MD, et al.
Published: (2016-06-01)

Fulminant Fournier’s gangrene in a patient with gastric cancer treated with ramucirumab and paclitaxel
by: Zoran Rakusic, et al.
Published: (2020-08-01)

Analysis of prognostic factors for survival in the Russian population of patients with disseminated gastric cancer, who received ramucirumab as secondline therapy in the RAMSELGA trial
by: N. S. Besova, et al.
Published: (2020-07-01)

Cost-Effectiveness of ramucirumab plus paclitaxel as a second-line therapy for advanced gastric or gastro-oesophageal cancer in China.
by: Sini Li, et al.
Published: (2020-01-01)

Improved efficacy of taxanes and ramucirumab combination chemotherapy after exposure to anti-PD-1 therapy in advanced gastric cancer
by: Saori Mishima, et al.
Published: (2020-10-01)

Spontaneous Splenic Rupture in Melanoma
by: Hadi Mirfazaelian, et al.
Published: (2014-01-01)

Spontaneous Rupture of Splenic Hemangioma in a Neonate
by: Bruno Martinez-Leo, et al.
Published: (2016-07-01)

A case of splenic artery pseudoaneurysm rupture in a bulimic patient with gastric ulcer
by: Lucio Brugioni, et al.
Published: (2020-06-01)

Splenic peliosis with spontaneous splenic rupture: report of two cases
by: Holbrook Anthony G, et al.
Published: (2006-06-01)

Clinical role of ramucirumab alone or in combination with paclitaxel for gastric and gastro-oesophageal junction adenocarcinoma
by: Davidson M, et al.
Published: (2016-07-01)

Ramucirumab combined with paclitaxel as the second-line chemotherapy for elderly patients with disseminated gastric cancer
by: T. A. Titova, et al.
Published: (2018-07-01)

The Efficacy of Ramucirumab in the Treatment of Gastric or Gastroesophageal Junction Cancer: A Meta-Analysis of RCTs
by: Hongqiong Yang, et al.
Published: (2021-01-01)

A case of ramucirumab-related gastrointestinal perforation in gastric cancer with small bowel metastasis
by: Shinya Urakawa, et al.
Published: (2017-12-01)

Splenic rupture after colorectal cancer screening
by: María José García-García, et al.
Published: (2015-11-01)

Splenic rupture in a patient on antiplatelet therapy – the role of splenic angioembolization
by: D.P. VENTER, et al.
Published: (2020-12-01)

Splenic Rupture following Transnasal Endoscopy
by: Mariana Ferreira Cardoso, et al.
Published: (2018-09-01)

Spontaneous splenic rupture in infectious mononucleosis
by: Odalović Božidar, et al.
Published: (2018-01-01)

Spontaneous splenic rupture in infectious mononucleosis
by: Al-Mashat Faisal, et al.
Published: (2003-01-01)

Atraumatic splenic rupture associated with apixaban
by: Sijan Basnet, et al.
Published: (2019-02-01)

Hemoperitoneum from splenic rupture in an expatriate
by: Massimo Tonolini, et al.
Published: (2012-01-01)

Spontaneous splenic rupture in infectious mononucleosis
by: B Koebrugge, et al.
Published: (2013-07-01)

A case of effective disease control of advanced gastric cancer following ramucirumab plus FOLFIRI in second line treatment in clinical practice
by: T. A. Titova, et al.
Published: (2020-12-01)

Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinoma
by: James J. Harding, et al.
Published: (2021-05-01)

Results of the use of ramucirumab in combination with irinotecan and fluoropyrimidines in the second-line chemotherapy for disseminated gastric cancer
by: N. S. Besova, et al.
Published: (2019-06-01)

Ramucirumab: preclinical research and clinical development
by: Aprile G, et al.
Published: (2014-10-01)

A case of splenic torsion and rupture presenting as ruptured ectopic pregnancy
by: Somdatta Lahiri, et al.
Published: (2010-12-01)

Fatal rupture of giant splenic artery pseudoaneurysm
by: Arun Prasad, et al.
Published: (2021-03-01)

Splenic rupture in an extremely low birthweight infant
by: Jennifer Hammond, et al.
Published: (2020-12-01)

Cannot write session to /tmp/vufind_sessions/sess_2lj2sv5uls1d345o9sa411q257